NovoCure Limited
NVCR
$15.23
$0.030.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -148.57M | -173.05M | -136.23M | -177.65M | -170.95M |
| Total Depreciation and Amortization | 14.79M | 13.93M | 13.13M | 12.17M | 10.96M |
| Total Amortization of Deferred Charges | 5.15M | 5.15M | 5.15M | 5.14M | 5.14M |
| Total Other Non-Cash Items | 115.40M | 127.51M | 88.99M | 126.05M | 124.58M |
| Change in Net Operating Assets | 10.41M | -430.00K | -20.08M | -186.00K | -14.41M |
| Cash from Operations | -2.82M | -26.88M | -49.03M | -34.48M | -44.68M |
| Capital Expenditure | -22.62M | -21.19M | -26.65M | -30.69M | -35.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 431.75M | 472.68M | 463.92M | 109.43M | 53.22M |
| Cash from Investing | 409.13M | 451.50M | 437.28M | 78.74M | 17.50M |
| Total Debt Issued | 99.98M | 99.98M | 99.98M | 99.98M | 0.00 |
| Total Debt Repaid | -560.95M | -560.95M | -560.95M | 0.00 | 0.00 |
| Issuance of Common Stock | 7.07M | 4.91M | 9.77M | 10.86M | 10.42M |
| Repurchase of Common Stock | -702.00K | -702.00K | -146.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -454.60M | -456.76M | -451.34M | 110.84M | 10.42M |
| Foreign Exchange rate Adjustments | -236.00K | 37.00K | 394.00K | 342.00K | 451.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.52M | -32.11M | -62.70M | 155.44M | -16.31M |